In a study conducted in Turkey, 45.7% of IgA-deficient patients presented with eczema, asthma, rhinitis, or atopic dermatitis; however, in a cohort of SIgAD patients in China, only 17% exhibited allergic symptoms (66, 67). This evidence concerns the gene CD79A and atopic eczema.